Overview

Nalmefene Smoking Cessation Study

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
To determine if nalmefene is safe and effective in smoking cessation.
Phase:
Phase 2
Details
Lead Sponsor:
Somaxon Pharmaceuticals
Treatments:
Nalmefene
Naltrexone